B+L launches PureVision2 Multi-Focal

Article

Bausch + Lomb introduced PureVision2 Multi-Focal (balafilcon A) monthly silicone hydrogel multifocal contact lenses at the American Academy of Optometry meeting. Featuring a next-generation 3-zone progressive design, these lenses are designed to improve near and intermediate vision while providing excellent distance clarity.

 

Seattle-Bausch + Lomb introduced PureVision2 Multi-Focal (balafilcon A) monthly silicone hydrogel multifocal contact lenses at the American Academy of Optometry meeting. Featuring a next-generation 3-zone progressive design, these lenses are designed to improve near and intermediate vision while providing excellent distance clarity.

The lens design allows for a more predictable, quick fit for the eyecare professional. According to the company, PureVision2 Multi-Focal helped maintain clear near, intermediate, and distance vision in real-world conditions.

The lenses are approved for extended wear up to 30 days in powers ranging from +6.00 D to –10.00 D in 0.25 D steps. Low add power helps patients needing 0.75 D to 1.50 D of near power, while the high add power addresses needs of 1.75 D to 2.50 D. Base curve is 8.6 mm, and diameter is 14.0 mm.

“We know that consistent, crisp, clear vision at all distances can be a challenge for people with presbyopia. These new lenses will provide that consistency whether viewing a screen on your mobile phone or a screen at the cinema,” said Joseph Barr, OD, MS, vice president, Medical Affairs, Pharmaceuticals, Vision Care, Bausch + Lomb. “We’re optimistic that the combination of a streamlined fit and a satisfied patient will make this lens a favorite for the eyecare professional.”

 

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.